Moderna starts late-stage COVID-19 vaccine trial, 30,000 volunteers to receive shots
Health / Moderna starts late-stage COVID-19 vaccine trial, 30,000 volunteers to receive shots
Health - Moderna starts late-stage COVID-19 vaccine trial, 30,000 volunteers to receive shots
New York: Moderna Inc said on Monday it has started a U.S. government-backed late-stage trial evaluating its COVID-19 vaccine candidate, mRNA-1273, in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.The main goal of the study will be prevention of the symptomatic COVID-19 disease, the company said.